[Form 4] H.B. Fuller Company Insider Trading Activity
Rhea-AI Filing Summary
Michael J. Happe, a director of H.B. Fuller Company (FUL), reported transactions on 08/29/2025. He disposed of 1,343 shares of common stock. The filing also reports acquisition of 450.45 stock units under the Directors' Deferred Compensation Plan that convert 1-for-1 into common shares and will convert on retirement, death, disability or certain specified events, subject to holding periods. The reported holdings after the transactions equal 13,390.71 shares beneficially owned, which includes stock units credited as dividend equivalents. The form was signed by an attorney-in-fact on 09/02/2025.
Positive
- Disclosure compliance observed with timely Form 4 reporting and attorney-in-fact signature
- Continued material ownership: beneficial ownership remains 13,390.71 shares, showing retention of stake
- Deferred compensation conversion terms are disclosed (1-for-1 conversion and triggering events)
Negative
- Disposition of 1,343 common shares by a director, indicating insider liquidity
- No price reported for the 1,343-share disposition on the form (price field not shown)
Insights
TL;DR: Routine director sale with deferred-compensation stock units added; overall holdings remain material but no new operational signal.
The Form 4 discloses a disposition of 1,343 common shares and the grant/crediting of 450.45 stock units under the Directors' Deferred Compensation Plan that convert 1-for-1 under defined events. Reported beneficial ownership after the transactions is 13,390.71 shares, including units from a dividend-equivalent feature. This is a compliance filing showing insider liquidity and deferred compensation mechanics rather than an operational development. There are no exercise prices or option expirations that affect short-term dilution.
TL;DR: Standard Section 16 disclosure: director sale plus deferred-comp plan crediting; documentation and conversion terms are disclosed.
The filing properly identifies the reporting person as a director and notes transactions dated 08/29/2025. The stock units are described with conversion and triggering events and include dividend-equivalent credits, which align with common deferred-comp arrangements for directors. The signature by an attorney-in-fact is present and dated 09/02/2025. No protocol exceptions or unusual vesting anomalies are disclosed in the form.